Acadian Asset Management LLC Esperion Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $130,892 - $244,059	136,346 New	136,346 $131,000
Q2 2020 Aug 12, 2020	SELL	$30.04 - $51.31 $40,974 - $69,986	-1,364 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$27.44 - $73.84 $37,428 - $100,717	1,364 New	1,364 $43,000
Q4 2019 Feb 06, 2020	SELL	$35.4 - $59.82 $140,042 - $236,647	-3,956 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$34.47 - $47.53 $451,246 - $622,215	-13,091 Reduced 76.79%	3,956 $145,000
Q2 2019 Aug 08, 2019	BUY	$40.1 - $52.33 $683,584 - $892,069	17,047 New	17,047 $793,000

215

129M

1.78M

1.27M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $123M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.